Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxf2
|
ENSMUSG00000038402.2 | forkhead box F2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxf2 | mm10_chr13_31672196_31672351 | 0.54 | 2.3e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_53105833_53106109 | 16.73 |
Prpf40a |
pre-mRNA processing factor 40A |
39338 |
0.2 |
chr3_17791724_17791875 | 15.57 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1842 |
0.32 |
chr13_77864958_77865113 | 13.64 |
Fam172a |
family with sequence similarity 172, member A |
156251 |
0.04 |
chr15_54921010_54921324 | 12.73 |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
1042 |
0.54 |
chr1_169187638_169187982 | 12.29 |
Gm37839 |
predicted gene, 37839 |
159822 |
0.04 |
chr6_15285298_15285547 | 11.99 |
Foxp2 |
forkhead box P2 |
31139 |
0.25 |
chr6_8956269_8957017 | 11.37 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr18_64889548_64889699 | 11.24 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
594 |
0.63 |
chr19_31188612_31188763 | 10.78 |
Gm50266 |
predicted gene, 50266 |
76141 |
0.12 |
chr1_81594178_81594459 | 10.70 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr4_35125928_35126141 | 10.18 |
Ifnk |
interferon kappa |
26022 |
0.16 |
chr6_12750644_12750848 | 10.11 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
1336 |
0.49 |
chr12_48222098_48222420 | 9.54 |
Gm46327 |
predicted gene, 46327 |
174725 |
0.03 |
chr6_25437965_25438240 | 9.35 |
Gm22529 |
predicted gene, 22529 |
238051 |
0.02 |
chr5_131532078_131532239 | 9.32 |
Auts2 |
autism susceptibility candidate 2 |
2239 |
0.3 |
chr5_70842284_70842796 | 9.25 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
77 |
0.99 |
chr17_69230455_69230719 | 9.05 |
Epb41l3 |
erythrocyte membrane protein band 4.1 like 3 |
13049 |
0.22 |
chrX_141725754_141725924 | 8.90 |
Irs4 |
insulin receptor substrate 4 |
576 |
0.59 |
chr2_107945942_107946093 | 8.76 |
Gm23439 |
predicted gene, 23439 |
59378 |
0.16 |
chr14_122402871_122403112 | 8.73 |
Gm5089 |
predicted gene 5089 |
3752 |
0.2 |
chr2_41498351_41498548 | 8.71 |
Lrp1b |
low density lipoprotein-related protein 1B |
290629 |
0.01 |
chr13_83736510_83736661 | 8.58 |
Gm33366 |
predicted gene, 33366 |
1950 |
0.2 |
chr12_47162854_47163202 | 8.29 |
Gm36971 |
predicted gene, 36971 |
2014 |
0.43 |
chr16_5811108_5811272 | 8.13 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
74165 |
0.12 |
chr2_28882454_28882605 | 7.98 |
Ddx31 |
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31 |
25388 |
0.13 |
chr9_61550073_61550272 | 7.79 |
Gm34424 |
predicted gene, 34424 |
16757 |
0.23 |
chr7_30291145_30292058 | 7.74 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
127 |
0.89 |
chr13_84783122_84783632 | 7.73 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chr4_149098903_149099213 | 7.55 |
Pex14 |
peroxisomal biogenesis factor 14 |
751 |
0.51 |
chr12_35008814_35009043 | 7.46 |
Prps1l1 |
phosphoribosyl pyrophosphate synthetase 1-like 1 |
24167 |
0.17 |
chr11_17460047_17460676 | 7.37 |
Gm12015 |
predicted gene 12015 |
161942 |
0.03 |
chr1_19217099_19217250 | 7.36 |
Tfap2b |
transcription factor AP-2 beta |
3295 |
0.25 |
chr4_82690701_82691000 | 7.15 |
Gm11269 |
predicted gene 11269 |
1955 |
0.35 |
chr8_26472218_26472423 | 7.15 |
Gm31983 |
predicted gene, 31983 |
3480 |
0.23 |
chr11_84376197_84376348 | 7.10 |
Aatf |
apoptosis antagonizing transcription factor |
73261 |
0.1 |
chr1_42231212_42231404 | 7.03 |
Gm9915 |
predicted gene 9915 |
1581 |
0.37 |
chr13_82971734_82971898 | 6.92 |
2310067P03Rik |
RIKEN cDNA 2310067P03 gene |
93641 |
0.09 |
chr7_82175368_82175629 | 6.87 |
Sh3gl3 |
SH3-domain GRB2-like 3 |
264 |
0.8 |
chr7_129937635_129938453 | 6.69 |
Gm4265 |
predicted gene 4265 |
24121 |
0.24 |
chr8_34709987_34710138 | 6.69 |
Gm45627 |
predicted gene 45627 |
50693 |
0.13 |
chr2_50568912_50569074 | 6.56 |
Gm13485 |
predicted gene 13485 |
21079 |
0.19 |
chr9_9673349_9673594 | 6.50 |
Gm26195 |
predicted gene, 26195 |
2430 |
0.4 |
chr9_102354569_102355215 | 6.32 |
Ephb1 |
Eph receptor B1 |
199 |
0.94 |
chr14_15785133_15785550 | 6.30 |
Gm31804 |
predicted gene, 31804 |
11652 |
0.26 |
chr1_42539688_42540042 | 6.24 |
Gm37047 |
predicted gene, 37047 |
48052 |
0.15 |
chr8_90069471_90069806 | 6.24 |
Tox3 |
TOX high mobility group box family member 3 |
278488 |
0.01 |
chr3_147181519_147181693 | 6.17 |
Gm6074 |
predicted gene 6074 |
11312 |
0.27 |
chr1_85114233_85115011 | 6.15 |
Gm16038 |
predicted gene 16038 |
697 |
0.48 |
chr2_156143561_156144291 | 6.11 |
Romo1 |
reactive oxygen species modulator 1 |
113 |
0.65 |
chr3_127746454_127746629 | 6.01 |
Gm23279 |
predicted gene, 23279 |
14947 |
0.11 |
chr1_78167977_78168321 | 5.94 |
Pax3 |
paired box 3 |
28689 |
0.2 |
chr13_103248251_103248426 | 5.94 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
76809 |
0.1 |
chr16_6965041_6965355 | 5.91 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
104648 |
0.08 |
chr2_4222047_4222234 | 5.89 |
Gm38348 |
predicted gene, 38348 |
5059 |
0.19 |
chr19_41190963_41191114 | 5.86 |
Tll2 |
tolloid-like 2 |
15736 |
0.23 |
chr18_8911913_8912152 | 5.84 |
Gm37148 |
predicted gene, 37148 |
16203 |
0.25 |
chr7_92985099_92985250 | 5.83 |
Gm31663 |
predicted gene, 31663 |
3122 |
0.24 |
chr14_74696794_74696945 | 5.82 |
Gm9212 |
predicted gene 9212 |
20843 |
0.19 |
chr4_151139945_151140096 | 5.81 |
Camta1 |
calmodulin binding transcription activator 1 |
436 |
0.86 |
chr3_9833533_9834642 | 5.81 |
Pag1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
408 |
0.84 |
chr11_50887848_50888049 | 5.76 |
Zfp454 |
zinc finger protein 454 |
297 |
0.81 |
chr12_70108160_70108442 | 5.75 |
Nin |
ninein |
3270 |
0.2 |
chr10_119684387_119684717 | 5.75 |
Grip1 |
glutamate receptor interacting protein 1 |
7502 |
0.21 |
chr11_24452241_24452584 | 5.72 |
Gm12068 |
predicted gene 12068 |
26166 |
0.18 |
chr1_133265100_133265672 | 5.71 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
4070 |
0.17 |
chr10_25929030_25929439 | 5.68 |
Gm47939 |
predicted gene, 47939 |
29955 |
0.15 |
chr9_9707706_9707864 | 5.67 |
Gm26195 |
predicted gene, 26195 |
36744 |
0.21 |
chr3_137529694_137529872 | 5.65 |
Gm4861 |
predicted gene 4861 |
22839 |
0.2 |
chr17_56078902_56079299 | 5.53 |
Hdgfl2 |
HDGF like 2 |
534 |
0.58 |
chr7_91263023_91263211 | 5.53 |
Gm24552 |
predicted gene, 24552 |
20122 |
0.18 |
chr7_101833990_101834302 | 5.51 |
Gm10602 |
predicted gene 10602 |
2357 |
0.13 |
chr13_114144782_114144933 | 5.50 |
A430090L17Rik |
RIKEN cDNA A430090L17 gene |
6735 |
0.22 |
chr13_20901765_20901916 | 5.47 |
Gm25605 |
predicted gene, 25605 |
57086 |
0.11 |
chr14_80216319_80216498 | 5.40 |
Gm17923 |
predicted gene, 17923 |
1478 |
0.55 |
chr2_39210850_39211001 | 5.39 |
Gm13511 |
predicted gene 13511 |
6369 |
0.12 |
chr7_53017690_53017857 | 5.37 |
Gm22444 |
predicted gene, 22444 |
90703 |
0.1 |
chr11_24099868_24100309 | 5.35 |
Gm12064 |
predicted gene 12064 |
15317 |
0.14 |
chr10_87500649_87500815 | 5.34 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
7072 |
0.19 |
chr1_185193542_185193817 | 5.30 |
Rab3gap2 |
RAB3 GTPase activating protein subunit 2 |
10438 |
0.15 |
chr7_79511689_79511882 | 5.28 |
2900037B21Rik |
RIKEN cDNA 2900037B21 gene |
1139 |
0.24 |
chr13_18856504_18856675 | 5.27 |
Vps41 |
VPS41 HOPS complex subunit |
11726 |
0.23 |
chr7_81762289_81763575 | 5.25 |
Ramac |
RNA guanine-7 methyltransferase activating subunit |
7 |
0.96 |
chr1_75786505_75786826 | 5.25 |
Gm5257 |
predicted gene 5257 |
150275 |
0.03 |
chr17_29929077_29929256 | 5.14 |
Gm16758 |
predicted gene, 16758 |
39082 |
0.1 |
chr16_77788297_77788506 | 5.07 |
Gm17333 |
predicted gene, 17333 |
58203 |
0.11 |
chrX_161997506_161998003 | 5.05 |
Gm26317 |
predicted gene, 26317 |
71703 |
0.11 |
chr6_118724930_118725081 | 5.04 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
17858 |
0.25 |
chr4_5962411_5962640 | 5.00 |
Gm11796 |
predicted gene 11796 |
107038 |
0.07 |
chr8_58912252_58913386 | 4.97 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
179 |
0.83 |
chr6_58895029_58895188 | 4.96 |
Herc3 |
hect domain and RLD 3 |
5013 |
0.2 |
chr10_69764414_69764625 | 4.95 |
Ank3 |
ankyrin 3, epithelial |
20995 |
0.28 |
chr5_63767639_63767820 | 4.95 |
Nwd2 |
NACHT and WD repeat domain containing 2 |
32733 |
0.17 |
chr4_119761572_119761735 | 4.92 |
Hivep3 |
human immunodeficiency virus type I enhancer binding protein 3 |
408 |
0.89 |
chr12_98563216_98563398 | 4.91 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
11405 |
0.14 |
chr11_38856747_38856914 | 4.90 |
Gm23520 |
predicted gene, 23520 |
58553 |
0.17 |
chr9_56506977_56507295 | 4.89 |
Gm47175 |
predicted gene, 47175 |
475 |
0.78 |
chr3_26827290_26827528 | 4.88 |
Gm37659 |
predicted gene, 37659 |
185355 |
0.03 |
chr14_18238252_18238719 | 4.88 |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
526 |
0.71 |
chr4_149595007_149595184 | 4.86 |
Clstn1 |
calsyntenin 1 |
7847 |
0.13 |
chr12_26086976_26087127 | 4.85 |
Gm47750 |
predicted gene, 47750 |
63265 |
0.13 |
chr1_118911733_118911884 | 4.84 |
Mir6346 |
microRNA 6346 |
42412 |
0.16 |
chr11_8456656_8457180 | 4.82 |
Tns3 |
tensin 3 |
11757 |
0.29 |
chr12_119189819_119190217 | 4.82 |
Itgb8 |
integrin beta 8 |
48752 |
0.15 |
chr7_91208818_91209022 | 4.76 |
Gm24552 |
predicted gene, 24552 |
34075 |
0.14 |
chr3_17592524_17592749 | 4.76 |
Gm38154 |
predicted gene, 38154 |
78052 |
0.11 |
chr2_105613478_105613629 | 4.74 |
Paupar |
Pax6 upstream antisense RNA |
47790 |
0.11 |
chr12_44403738_44404185 | 4.68 |
Gm48182 |
predicted gene, 48182 |
5829 |
0.21 |
chr3_51096175_51096378 | 4.67 |
Gm38246 |
predicted gene, 38246 |
7384 |
0.2 |
chr14_37032573_37032946 | 4.63 |
Gm47885 |
predicted gene, 47885 |
8225 |
0.15 |
chr3_87098356_87098639 | 4.63 |
Gm24472 |
predicted gene, 24472 |
31604 |
0.12 |
chr9_14245307_14245458 | 4.60 |
Gm47565 |
predicted gene, 47565 |
5557 |
0.17 |
chr14_10453354_10453845 | 4.59 |
Fhit |
fragile histidine triad gene |
141 |
0.97 |
chr14_12391498_12391668 | 4.59 |
Gm48267 |
predicted gene, 48267 |
10647 |
0.13 |
chr9_68347558_68347709 | 4.57 |
Gm22382 |
predicted gene, 22382 |
67059 |
0.11 |
chr3_39460563_39460812 | 4.56 |
Gm9845 |
predicted pseudogene 9845 |
101784 |
0.08 |
chr15_34824497_34824736 | 4.55 |
Gm48932 |
predicted gene, 48932 |
1813 |
0.39 |
chr17_87611074_87611259 | 4.55 |
Epcam |
epithelial cell adhesion molecule |
24813 |
0.15 |
chr15_10746665_10746863 | 4.50 |
4930556M19Rik |
RIKEN cDNA 4930556M19 gene |
28913 |
0.16 |
chr13_42150594_42150745 | 4.48 |
Hivep1 |
human immunodeficiency virus type I enhancer binding protein 1 |
6465 |
0.29 |
chr8_123795414_123795565 | 4.47 |
Rab4a |
RAB4A, member RAS oncogene family |
10496 |
0.09 |
chr2_65414317_65414615 | 4.46 |
Gm24138 |
predicted gene, 24138 |
38184 |
0.13 |
chr4_137468219_137468852 | 4.42 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
234 |
0.9 |
chr6_5800765_5800916 | 4.42 |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
43421 |
0.2 |
chr8_90669322_90669473 | 4.42 |
Gm45639 |
predicted gene 45639 |
5561 |
0.21 |
chr14_66320257_66320561 | 4.41 |
Gm41183 |
predicted gene, 41183 |
20820 |
0.13 |
chr19_21035621_21035799 | 4.39 |
4930554I06Rik |
RIKEN cDNA 4930554I06 gene |
68792 |
0.11 |
chr9_78615394_78615551 | 4.38 |
Cd109 |
CD109 antigen |
74 |
0.97 |
chrX_7721605_7722047 | 4.36 |
Wdr45 |
WD repeat domain 45 |
147 |
0.74 |
chr7_86775632_86776070 | 4.36 |
Folh1 |
folate hydrolase 1 |
43 |
0.98 |
chr7_137250849_137251016 | 4.36 |
Gm10578 |
predicted gene 10578 |
16249 |
0.17 |
chr1_128399169_128399323 | 4.33 |
Dars |
aspartyl-tRNA synthetase |
18113 |
0.16 |
chr10_86425574_86426115 | 4.33 |
Syn3 |
synapsin III |
66053 |
0.08 |
chr1_59423065_59423318 | 4.32 |
Gm37737 |
predicted gene, 37737 |
26311 |
0.14 |
chr19_31743298_31743566 | 4.31 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
21541 |
0.26 |
chr2_168611107_168611283 | 4.30 |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
9538 |
0.21 |
chr13_110280472_110281172 | 4.30 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr6_106916863_106917143 | 4.27 |
Gm22418 |
predicted gene, 22418 |
84449 |
0.09 |
chr6_28370428_28370579 | 4.26 |
Gm5303 |
predicted gene 5303 |
7338 |
0.16 |
chr7_136060647_136060798 | 4.26 |
Gm9341 |
predicted gene 9341 |
107924 |
0.06 |
chr9_91350520_91350671 | 4.26 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
358 |
0.77 |
chr5_91875962_91876131 | 4.25 |
Gm43688 |
predicted gene 43688 |
37357 |
0.11 |
chr16_27925838_27926060 | 4.20 |
Gm49765 |
predicted gene, 49765 |
44396 |
0.17 |
chr15_92994221_92994384 | 4.20 |
Gm30085 |
predicted gene, 30085 |
7522 |
0.22 |
chr6_147061739_147061930 | 4.19 |
Mrps35 |
mitochondrial ribosomal protein S35 |
583 |
0.66 |
chr5_112521223_112521397 | 4.16 |
Sez6l |
seizure related 6 homolog like |
46183 |
0.1 |
chr6_33739442_33739593 | 4.16 |
Exoc4 |
exocyst complex component 4 |
38083 |
0.19 |
chr2_147702775_147702949 | 4.15 |
A530006G24Rik |
RIKEN cDNA A530006G24 gene |
7831 |
0.23 |
chr3_9974287_9974636 | 4.14 |
Gm17877 |
predicted gene, 17877 |
2460 |
0.27 |
chr5_52509515_52509784 | 4.13 |
Gm43685 |
predicted gene 43685 |
29182 |
0.12 |
chr6_103377396_103377547 | 4.12 |
Gm44295 |
predicted gene, 44295 |
97485 |
0.07 |
chr3_80801741_80801936 | 4.12 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
741 |
0.75 |
chr11_4660422_4660608 | 4.11 |
Ascc2 |
activating signal cointegrator 1 complex subunit 2 |
22768 |
0.12 |
chr5_71010916_71011067 | 4.10 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
2693 |
0.43 |
chr6_36876440_36876591 | 4.10 |
1700111E14Rik |
RIKEN cDNA 1700111E14 gene |
60533 |
0.12 |
chr17_28869526_28869677 | 4.10 |
Pnpla1os |
patatin-like phospholipase domain containing 1, opposite strand |
10093 |
0.1 |
chr8_84936253_84936414 | 4.09 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
1011 |
0.26 |
chr19_14507172_14507352 | 4.09 |
Tle4 |
transducin-like enhancer of split 4 |
88277 |
0.1 |
chr8_23425291_23425763 | 4.09 |
Sfrp1 |
secreted frizzled-related protein 1 |
14025 |
0.25 |
chr1_97938185_97938336 | 4.06 |
Gm3531 |
predicted pseudogene 3531 |
11129 |
0.2 |
chr10_72298914_72299065 | 4.06 |
Gm9923 |
predicted pseudogene 9923 |
10332 |
0.31 |
chr12_58670274_58670654 | 4.04 |
Gm18873 |
predicted gene, 18873 |
93442 |
0.08 |
chr14_98650588_98650739 | 4.02 |
Gm26139 |
predicted gene, 26139 |
26473 |
0.22 |
chr11_25156710_25156955 | 3.99 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
75794 |
0.11 |
chr8_70522463_70523590 | 3.99 |
Kxd1 |
KxDL motif containing 1 |
64 |
0.93 |
chr8_13624763_13625235 | 3.98 |
Rasa3 |
RAS p21 protein activator 3 |
18891 |
0.17 |
chr10_89195159_89195310 | 3.96 |
Ano4 |
anoctamin 4 |
61902 |
0.14 |
chr8_41815390_41815553 | 3.95 |
2810404M03Rik |
RIKEN cDNA 2810404M03 gene |
11796 |
0.28 |
chr7_31148783_31149449 | 3.95 |
G630030J09Rik |
RIKEN cDNA G630030J09 gene |
412 |
0.68 |
chr6_113890672_113891135 | 3.94 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
467 |
0.81 |
chr10_39535386_39535619 | 3.92 |
Fyn |
Fyn proto-oncogene |
2232 |
0.3 |
chr16_5884865_5885135 | 3.92 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
355 |
0.93 |
chr2_4041994_4042180 | 3.91 |
Gm2639 |
predicted gene 2639 |
10472 |
0.15 |
chrX_58155690_58155914 | 3.91 |
Gm14649 |
predicted gene 14649 |
28684 |
0.21 |
chr15_39783070_39783242 | 3.90 |
Dpys |
dihydropyrimidinase |
10095 |
0.19 |
chr4_54331918_54332142 | 3.90 |
Gm12469 |
predicted gene 12469 |
96154 |
0.08 |
chr5_5342384_5343082 | 3.90 |
Gm43728 |
predicted gene 43728 |
31110 |
0.15 |
chr16_77685559_77685884 | 3.87 |
Gm37694 |
predicted gene, 37694 |
444 |
0.75 |
chr3_148559878_148560070 | 3.85 |
Gm38068 |
predicted gene, 38068 |
9090 |
0.28 |
chr3_122247078_122247551 | 3.81 |
Gclm |
glutamate-cysteine ligase, modifier subunit |
1233 |
0.27 |
chr2_148874636_148875322 | 3.81 |
Cst3 |
cystatin C |
472 |
0.73 |
chr17_90628542_90628972 | 3.81 |
Nrxn1 |
neurexin I |
1270 |
0.58 |
chr18_39078663_39078822 | 3.80 |
Arhgap26 |
Rho GTPase activating protein 26 |
20569 |
0.24 |
chr2_159393037_159393200 | 3.78 |
Gm14219 |
predicted gene 14219 |
63339 |
0.15 |
chr10_128673048_128673414 | 3.77 |
Suox |
sulfite oxidase |
842 |
0.34 |
chr3_82030086_82030237 | 3.74 |
Gucy1b1 |
guanylate cyclase 1, soluble, beta 1 |
5161 |
0.2 |
chr4_89295028_89295448 | 3.72 |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
585 |
0.7 |
chr19_15983108_15983336 | 3.70 |
Cep78 |
centrosomal protein 78 |
1471 |
0.32 |
chr13_15759168_15760299 | 3.69 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr13_119408014_119408896 | 3.69 |
Nnt |
nicotinamide nucleotide transhydrogenase |
497 |
0.78 |
chr6_12606704_12606883 | 3.69 |
Gm44129 |
predicted gene, 44129 |
2203 |
0.36 |
chr1_16228282_16228916 | 3.69 |
Gm28095 |
predicted gene 28095 |
93 |
0.97 |
chr11_35287153_35287304 | 3.68 |
Gm12123 |
predicted gene 12123 |
36442 |
0.18 |
chr16_62690482_62690670 | 3.67 |
Gm9816 |
predicted pseudogene 9816 |
26461 |
0.19 |
chr12_71976877_71977033 | 3.65 |
Gm7986 |
predicted gene 7986 |
72304 |
0.08 |
chr9_87015281_87015918 | 3.65 |
Ripply2 |
ripply transcriptional repressor 2 |
37 |
0.97 |
chr1_105908369_105908838 | 3.64 |
Gm37779 |
predicted gene, 37779 |
17591 |
0.16 |
chr6_94401148_94401552 | 3.64 |
Gm7825 |
predicted gene 7825 |
16479 |
0.2 |
chr1_89550612_89550805 | 3.63 |
Gm25180 |
predicted gene, 25180 |
12652 |
0.18 |
chr3_14579547_14579746 | 3.61 |
E2f5 |
E2F transcription factor 5 |
975 |
0.46 |
chr2_168721349_168721648 | 3.61 |
Atp9a |
ATPase, class II, type 9A |
8536 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.4 | 7.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.4 | 6.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.4 | 6.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.3 | 3.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.0 | 3.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.0 | 3.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.0 | 6.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.0 | 3.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.0 | 2.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.9 | 4.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.9 | 3.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.9 | 1.7 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.8 | 2.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.8 | 3.2 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.8 | 4.5 | GO:0048840 | otolith development(GO:0048840) |
0.7 | 2.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 2.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.7 | 2.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 6.2 | GO:0031223 | auditory behavior(GO:0031223) |
0.7 | 2.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 2.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.7 | 2.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.7 | 4.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.6 | 3.8 | GO:0001302 | replicative cell aging(GO:0001302) |
0.6 | 0.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.6 | 1.9 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.6 | 2.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.6 | 1.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 2.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.6 | 1.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.6 | 1.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.5 | 1.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 2.1 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.5 | 3.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.5 | 1.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 11.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 2.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.5 | 3.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.5 | 1.4 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.5 | 2.3 | GO:0072017 | distal tubule development(GO:0072017) |
0.4 | 1.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.4 | 1.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 1.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.4 | 1.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 0.9 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.4 | 1.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 1.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 1.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 1.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 1.2 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.4 | 1.2 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.4 | 1.9 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.4 | 1.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 2.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 1.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 4.9 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 1.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.3 | 2.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 0.6 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 1.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 0.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.3 | 0.9 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 7.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 0.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.3 | 2.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 2.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 0.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.3 | 2.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 1.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.6 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 0.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.3 | 2.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 0.8 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 1.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 1.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 1.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 1.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 0.7 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.9 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 3.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 1.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 1.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.2 | 2.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.8 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 1.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 1.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.6 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.2 | 5.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 0.8 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 2.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 1.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.0 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.2 | 1.7 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 0.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.2 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.2 | 0.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.5 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.2 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 1.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.5 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.2 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.9 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 2.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 2.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.2 | 1.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 4.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 1.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.3 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 1.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.6 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.1 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 1.4 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.1 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 3.6 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.1 | 0.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.1 | 0.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 1.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.8 | GO:0042558 | pteridine-containing compound metabolic process(GO:0042558) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.8 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.8 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 1.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.1 | 0.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.2 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.9 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.6 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 1.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.9 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 1.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.1 | GO:0060596 | mammary gland formation(GO:0060592) mammary placode formation(GO:0060596) |
0.1 | 0.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 4.4 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 6.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 1.3 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.3 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.1 | 4.0 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.5 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 2.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 1.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:0071599 | otic vesicle development(GO:0071599) |
0.1 | 0.3 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.1 | 0.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.3 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.2 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.1 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.1 | 1.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.1 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 0.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.1 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 1.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 1.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.3 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.5 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.5 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.4 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 4.4 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.2 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.3 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.2 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 1.6 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.0 | 0.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.0 | 0.2 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.0 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.2 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 1.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 1.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.8 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 1.4 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.1 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.0 | 0.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.0 | 1.9 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.0 | GO:1901166 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.0 | 0.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.0 | 0.0 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.0 | 0.2 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.0 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.1 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.0 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.3 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 1.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.0 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.0 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.0 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.0 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.1 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.0 | 0.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.0 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.0 | 0.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.3 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.0 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.3 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 1.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 0.0 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.0 | 0.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.0 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 2.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.8 | 2.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 11.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 1.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.6 | 1.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 1.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 1.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 5.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 3.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.4 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 1.7 | GO:0001652 | granular component(GO:0001652) |
0.3 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 6.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 2.0 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 5.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 2.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 2.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 3.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 2.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 3.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 3.8 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 1.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 2.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.4 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 1.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 5.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 4.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.1 | 2.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 4.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 4.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 2.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 1.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 1.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 1.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 1.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 1.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 1.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 1.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 1.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 3.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 1.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 1.4 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 4.7 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.3 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 1.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.5 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.0 | GO:0070069 | cytochrome complex(GO:0070069) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.9 | GO:0097001 | ceramide binding(GO:0097001) |
1.7 | 6.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.3 | 3.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.2 | 7.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.1 | 3.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.0 | 3.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 5.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.0 | 2.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.9 | 2.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 3.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.8 | 4.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.8 | 3.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 2.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 2.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.7 | 9.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.7 | 2.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.6 | 5.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.6 | 1.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 1.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.6 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 2.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 2.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 1.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 1.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 2.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 6.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 2.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 3.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 2.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 1.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 1.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 4.3 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 3.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 1.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 1.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 3.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 3.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 1.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 3.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 2.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 2.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 1.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.7 | GO:0032564 | dATP binding(GO:0032564) |
0.2 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 2.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 1.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 2.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 4.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.6 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 1.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 2.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.0 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.4 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 3.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 2.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 2.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 2.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.2 | GO:0008758 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.4 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 1.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 1.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 4.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 1.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 1.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 2.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 6.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.5 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.0 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 2.4 | GO:0033931 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) O antigen polymerase activity(GO:0008755) lipopolysaccharide-1,6-galactosyltransferase activity(GO:0008921) cellulose synthase activity(GO:0016759) 9-phenanthrol UDP-glucuronosyltransferase activity(GO:0018715) 1-phenanthrol glycosyltransferase activity(GO:0018716) 9-phenanthrol glycosyltransferase activity(GO:0018717) 1,2-dihydroxy-phenanthrene glycosyltransferase activity(GO:0018718) phenanthrol glycosyltransferase activity(GO:0019112) alpha-1,2-galactosyltransferase activity(GO:0031278) dolichyl pyrophosphate Man7GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0033556) endogalactosaminidase activity(GO:0033931) lipopolysaccharide-1,5-galactosyltransferase activity(GO:0035496) dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042283) inositol phosphoceramide synthase activity(GO:0045140) alpha-(1->3)-fucosyltransferase activity(GO:0046920) indole-3-butyrate beta-glucosyltransferase activity(GO:0052638) salicylic acid glucosyltransferase (ester-forming) activity(GO:0052639) salicylic acid glucosyltransferase (glucoside-forming) activity(GO:0052640) benzoic acid glucosyltransferase activity(GO:0052641) chondroitin hydrolase activity(GO:0052757) dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity(GO:0052824) cytokinin 9-beta-glucosyltransferase activity(GO:0080062) |
0.0 | 0.4 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 1.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.0 | 1.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 1.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 1.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 1.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 2.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 1.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 4.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 4.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 4.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 1.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.9 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 0.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.0 | 0.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 6.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 3.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 1.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 6.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 3.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 3.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 4.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 1.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 4.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 3.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 5.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 2.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 3.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 1.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.3 | 7.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 5.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 2.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 4.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 2.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 1.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 2.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 2.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 4.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 4.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 4.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 2.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 1.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 1.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 1.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |